Ontario Opioid Drug Observatory

In 2017, the ODPRN was funded by the Canadian Institutes for Health Research (CIHR) to establish an Ontario Opioid Drug Observatory with the goal of bringing together knowledge users, researchers and data to inform and evaluate opioid policy across Ontario. As the opioid crisis has worsened, this need for evidence has grown and evolved. Through the innovative work of the OODO, we have supported the linkage of all opioid prescriptions, opioid-related deaths, and pharmacy-dispensed naloxone to other health administrative databases across the province; the largest, most complete linked repository of data related to opioid use and related harms in Canada. More recently we have also supported the linkage of other substance toxicity deaths (stimulants, benzodiazepines and alcohol) to Ontario’s health administrative databases, opening the door to expanded research covering topics related to substance use and related harms more generally.
OODO logo e

The OODO Has Three Broad Objectives

Patterns of Use and Harm

To conduct ongoing analysis of trends in prescription opioid use and opioid-related harm (overdoses, infections, brain injuries) in Ontario and evaluate the impact of new drug policies and the COVID-19 pandemic on these measures.

Access to Treatment and Harm Reduction Strategies

To evaluate the safety, effectiveness, and barriers to accessing different forms of treatment for opioid use disorder (OUD) and harm reduction strategies (naloxone, safer opioid supply) across the province.

Pathways through Care

To assess how rapid access to treatment and primary care impact future patterns of healthcare use and patient outcomes among people hospitalized for serious opioid-related outcomes.

OODO Steering Committee

The Ontario Opioid Drug Observatory (OODO) is overseen by a steering committee comprised of people who use drugs, researchers, harm reduction workers, clinicians, and knowledge users who inform the development, interpretation and dissemination of this work. Click through to learn about the organizations/groups represented on this committee.
Learn more about the OODO Steering committee

OODO Lived Experience Advisory Group

The Ontario Opioid Drug Observatory (OODO) has taken a proactive, patient-centered approach through the development of the Lived Experience Advisory Group (LEAG).

Members of the LEAG ensure the relevance of opioid-related research from a person with lived experience perspective, provide feedback on initial research findings and their potential impact, and advise on dissemination strategies through personal and professional networks.

Learn more about the OODO Lived Experience Advisory Group

Highlighted OODO Projects

The Ontario Opioid Indicator Tool was developed by the OODO to provide public access to indicators of opioid use, opioid-related harms, and access to treatment and harm reduction in the province from 2012 onwards using data housed at ICES. It uses data from a variety of sources including the Narcotics Monitoring System (NMS), which captures all opioid prescriptions dispensed in retail pharmacies across Ontario, the Canadian Institute for Health Information National Ambulatory Care Reporting System and Discharge Abstract Database, and public health data.

This tool is designed to complement Public Health Ontario’s interactive Substance Use and Harms Tool which includes similarly presented indicators of opioid-related emergency department visits, hospitalizations and deaths.

Ontario Opioid Indicator Tool

View more

Together for Change: What we heard at the Community Substance Use Forum

View more

Opioid Toxicity and Access to Treatment among Adolescents and Young Adults in Ontario

View more

Sign up for our newsletter